Clinical Trial Update: NOVOCART 3D Treatment Following Microfracture Failure [Phase 3]

View source ↗

Summary

This update indicates that Aesculap Biologics' NOVOCART 3D is in a Phase 3 trial for articular cartilage defects after microfracture failure, with recruitment c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect

Drugs mentioned

• NOVOCART 3D

Snippet

Sponsor: Aesculap Biologics, LLC | Conditions: Articular Cartilage Defect | Phase 3 | Status: ACTIVE_NOT_RECRUITING